13F reference period
Q2 2026
Security Snapshot
Apogee Therapeutics, Inc. - Common Stock, par value $0.00001 per share (APGE) Institutional Ownership
CUSIP: 03770N101
13F Institutional Holders and Ownership History from Q3 2023 to Q3 2026
Institutions Reporting
288
Shares (Excl. Options)
67.57M
Full value: 67,568,805 · shares · 30 Jun 2026Price
$132.73
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Symbol
- APGE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 67,568,805
- Total 13F value
- $8,927,861,469
- Portfolio coverage rank
- 0.02%
- Share change
- -10,326,027
- Value change
- -$1,003,350,824
- Number of holders
- 288
- Underlying class
- Common Stock
- Shares outstanding
- 62,702,889
- SEC-reported price per share
- $135.08
- Insider filing price
- $135.08
Latest holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- APGE - Apogee Therapeutics, Inc. - Common Stock, par value $0.00001 per share is tracked under CUSIP 03770N101.
- 288 institutions reported positions in Q2 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 222 to 288 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$6.64B
Full value: $6,638,906,729 · USD · 31 Mar 2026.$8.93B
Full value: $8,927,861,469 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 288 institutions filings for Q2 2026.
Security key
03770N101
13F reference period
Q2 2026
13F holders
288
13D/G owners
6
CIK / CUSIP context first
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03770N101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
APGE
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 4.9% | -18% | $214,255,663 | 2,712,097 | 0% | RTW Investments, LP | 31 Dec 2025 | |
| BlackRock, Inc. | 5.5% | $109,396,539 | 2,518,725 | BlackRock, Inc. | 30 Jun 2025 | |||
| FMR LLC | 4% | -73% | $330,912,044 | -$585,861,778 | 2,493,137 | -64% | FMR LLC | 30 Jun 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4.7% | $85,757,284 | 2,158,502 | DRIEHAUS CAPITAL MANAGEMENT LLC | 30 Sep 2025 | |||
| T. Rowe Price Investment Management, Inc. | 1.3% | -91% | $102,595,557 | -$1,263,349,841 | 772,969 | -92% | T. Rowe Price Investment Management, Inc. | 30 Jun 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.9% | -87% | $74,902,539 | -$555,107,891 | 564,326 | -88% | Wellington Management Group LLP | 30 Jun 2026 |
As of 30 Jun 2026,
288
institutional investors reported holding
shares of
Apogee Therapeutics, Inc. - Common Stock, par value $0.00001 per share (APGE).
This represents
108%
of the company’s total
outstanding shares.
67.57M
Full value: 67,568,805 · shares · 30 Jun 202662.7M
Full value: 62,702,889 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
77%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Venrock Adviser, LLC | 14% | 8,493,321 | 0% | 34% | $1,127,318,496 |
| BlackRock, Inc. | 8.8% | 5,507,032 | +35% | 0.01% | $730,948,292 |
| HBK INVESTMENTS L P | 4.5% | 2,850,000 | 4.4% | $378,280,500 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.1% | 2,572,119 | +2.8% | 0.01% | $341,397,355 |
| FMR LLC | 4% | 2,493,137 | -73% | 0.01% | $330,914,038 |
| STATE STREET CORP | 3.7% | 2,297,743 | +6.2% | 0.01% | $304,979,428 |
| Driehaus Capital Management LLC | 2.8% | 1,740,101 | -9.4% | 1.3% | $230,963,606 |
| GOLDMAN SACHS GROUP INC | 2.7% | 1,693,341 | +159% | 0.02% | $224,757,151 |
| Balyasny Asset Management L.P. | 2.7% | 1,665,102 | +280% | 0.4% | $221,008,988 |
| GLAZER CAPITAL, LLC | 2.6% | 1,641,042 | 5.4% | $217,816,000 | |
| Paradigm Biocapital Advisors LP | 2.5% | 1,576,385 | +17% | 3.9% | $209,233,581 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.4% | 1,528,750 | +286% | 0.01% | $202,910,988 |
| MILLENNIUM MANAGEMENT LLC | 2.4% | 1,491,404 | +1511% | 0.13% | $197,954,053 |
| Pentwater Capital Management LP | 2.3% | 1,425,000 | 1.5% | $189,140,250 | |
| MORGAN STANLEY | 2.3% | 1,421,681 | +139% | 0.01% | $188,699,836 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.1% | 1,314,868 | +8% | 0.01% | $174,560,515 |
| PERCEPTIVE ADVISORS LLC | 2.1% | 1,308,113 | -15% | 2.7% | $173,625,838 |
| Jupiter Topco LLC | 1.9% | 1,193,626 | 0% | 0.06% | $158,402,405 |
| BANK OF AMERICA CORP /DE/ | 1.8% | 1,126,139 | +25% | 0.01% | $149,472,430 |
| Affinity Asset Advisors, LLC | 1.6% | 987,000 | -23% | 6.4% | $131,004,510 |
| MERCER GLOBAL ADVISORS INC /ADV | 1.5% | 941,283 | +13% | 0.15% | $124,936,493 |
| First Light Asset Management, LLC | 1.5% | 930,289 | +61% | 7.5% | $123,477,259 |
| ALLIANCEBERNSTEIN L.P. | 1.2% | 775,058 | -22% | 0.02% | $65,236,632 |
| T. Rowe Price Investment Management, Inc. | 1.2% | 762,183 | -93% | 0.07% | $101,165,000 |
| Kryger Capital LLC | 1.2% | 742,555 | 5.6% | $98,559,325 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
13
Headline period
Q2 2026
Rows shown
1-13 of 13
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 79 | $10,671 | -$44,633,274 | $135.08 | 1 |
| 2026 Q2 | 67,568,805 | $8,927,861,469 | -$1,003,350,824 | $132.73 | 288 |
| 2026 Q1 | 79,061,115 | $6,638,906,729 | +$743,266,174 | $84.17 | 222 |
| 2025 Q4 | 69,771,331 | $5,266,434,045 | +$762,006,154 | $75.48 | 206 |
| 2025 Q3 | 59,584,020 | $2,367,665,644 | +$56,487,603 | $39.73 | 173 |
| 2025 Q2 | 57,837,483 | $2,511,890,310 | -$147,322,983 | $43.43 | 180 |
| 2025 Q1 | 61,488,037 | $2,301,755,351 | +$131,273,115 | $37.36 | 165 |
| 2024 Q4 | 57,873,775 | $2,621,627,227 | +$63,332,544 | $45.30 | 156 |
| 2024 Q3 | 56,092,373 | $3,292,239,932 | +$134,148,823 | $58.74 | 137 |
| 2024 Q2 | 54,152,101 | $2,130,892,019 | -$9,800,456 | $39.35 | 137 |
| 2024 Q1 | 52,915,146 | $3,516,219,943 | +$778,331,224 | $66.45 | 137 |
| 2023 Q4 | 41,768,396 | $1,163,676,392 | +$48,111,524 | $27.94 | 85 |
| 2023 Q3 | 40,111,211 | $848,653,526 | +$848,653,497 | $21.30 | 73 |